Preterm Birth Drug Withdrawn After 12 Years
The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
Source: NYT Health - Category: Consumer Health News Authors: Christina Jewett Tags: Recalls and Bans of Products Premature Babies Pregnancy and Childbirth Drugs (Pharmaceuticals) Babies and Infants Covis Pharma Group Food and Drug Administration Source Type: news
More News: Babies | Food and Drug Administration (FDA) | Health | Perinatology & Neonatology | Pharmaceuticals | Pregnancy | Premature Birth | Study | Women